| Literature DB >> 35627029 |
Nevijo Zdolec1, Marta Kiš1, Dean Jankuloski2, Katerina Blagoevska2, Snježana Kazazić3, Marina Pavlak1, Bojan Blagojević4, Dragan Antić5, Maria Fredriksson-Ahomaa6, Valerij Pažin1.
Abstract
Yersinia enterocolitica is one of the priority biological hazards in pork inspection. Persistence of the pathogen, including strains resistant to antimicrobials, should be evaluated in pigs from different housing systems for risk ranking of farms. In this 2019 study, tonsils were collected from 234 pigs, of which 69 (29.5%) were fattened on 3 big integrated farms, 130 (55.5%) on 10 medium-sized farms, and 35 (15%) on 13 small family farms. In addition, 92 pork cuts and minced meat samples from the same farms were tested for the presence of Y. enterocolitica using the culture method. Phenotypic and genetic characteristics of the isolates were compared with previously collected isolates from 2014. The overall prevalence of Y. enterocolitica in pig tonsils was 43% [95% CI 36.7-49.7]. In pigs from big integrated, medium-sized, and small family farms, the prevalence was 29%, 52%, and 40%, respectively. All retail samples of portioned and minced pork tested negative for pathogenic Y. enterocolitica, likely due to high hygienic standards in slaughterhouses/cutting meat or low sensitivity of culture methods in these matrices. The highest recovery rate of the pathogen from tonsils was found when alkali-treated PSB and CIN agar were combined. The biosecurity category of integrated and medium farms did not affect the differences in prevalence of Y. enterocolitica (p > 0.05), in contrast to family farms. Pathogenic ail-positive Y. enterocolitica biotype 4 serotype O:3 persisted in the tonsils of pigs regardless of the type of farm, slaughterhouse, and year of isolation 2014 and 2019. PFGE typing revealed the high genetic concordance (80.6 to 100%) of all the Y. enterocolitica 4/O:3 isolates. A statistically significant higher prevalence of multidrug-resistant Y. enterocolitica 4/O:3 isolates was detected in the tonsils of pigs from big integrated farms compared to the other farm types (p < 0.05), with predominant and increasing resistance to nalidixic acid, chloramphenicol, and streptomycin. This study demonstrated multidrug resistance of the pathogen in pigs likely due to more antimicrobial pressure on big farms, with intriguing resistance to some clinically relevant antimicrobials used in the treatment of yersiniosis in humans.Entities:
Keywords: Yersinia enterocolitica 4/O:3; antimicrobial resistance; farm; pigs; slaughter
Year: 2022 PMID: 35627029 PMCID: PMC9140555 DOI: 10.3390/foods11101459
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Characteristics of slaughterhouses included in this study.
| Parameter | Slaughterhouse 1 | Slaughterhouse 2 | Slaughterhouse 3 | Slaughterhouse 4 |
|---|---|---|---|---|
| Number of slaughtered fattening pigs per year | 308,000 | 174,000 | 4000 | 55,000 |
| Number of slaughtered pigs/h | 130 | 160 | 20 | 140 |
| Risk category | High risk | High risk | Medium risk | High risk |
| Biosecurity of farms (sampled in this study) | 3 | 2–3 | 1–3 | 2 |
| Contact between pigs from different farms, lairage | No | Yes * | Yes * | Yes * |
| Scalding technology | Water (5 min/62 °C) | Steam (20 min/60 °C) | Water (10 min/62 °C) | Water (7 min, 61.5 °C) |
| Pluck set organ removal techniques and organ placement | Knife, conveyor belt | Knife, hanging hook | Knife, hanging hook | Knife, hanging hook |
| Head removal and processing on separate line | No | No | No | No |
* The pens in the lairage are separated by a fence that allows contact between the pigs.
Prevalence of Y. enterocolitica in tonsils of pigs from different housing systems and slaughterhouses.
| Slaughterhouse | Farm Type | Biosecurity | No. of Farms | YE + Farms | No. of Pigs | YE + Pigs ( | YE + Pigs (%) |
|---|---|---|---|---|---|---|---|
| 1 | Big integrated | 3 | 3 | 3 | 69 | 20 | 29% |
| 2 | Medium-sized | 2 and 3 | 6 | 6 | 74 | 31 | 42% |
| 3 | 5 | 5 | 62 | 24 | 39% | ||
| 2 | 1 | 1 | 12 | 7 | 58% | ||
| 3 | Medium-sized | 2 and 3 | 3 | 3 | 14 | 12 | 86% |
| 3 | 2 | 2 | 10 | 8 | 80% | ||
| 2 | 1 | 1 | 4 | 4 | 100% | ||
| Small family farms | 1, 2 and 3 | 13 | 8 | 35 | 14 | 40% | |
| 3 | 2 | 0 | 5 | 0 | 0 | ||
| 2 | 10 | 8 | 29 | 14 | 48% | ||
| 1 | 1 | 0 | 1 | 0 | 0 | ||
| 4 | Medium-sized | 3 | 1 | 1 | 42 | 24 | 57% |
| 26 | 21 | 234 | 101 | 43% |
Comparison of different methods regarding recovery rate and isolation of Y. enterocolitica from pig tonsils.
| Method of Isolation | Number of Positives (%); | |
|---|---|---|
| PSB and CIN | 14 (5.9) | 13.9 |
| PSB and CHROMagarTM | 18 (7.7) | 17.8 |
| PSB + KOH and CIN | 75 (32.0) | 74.3 |
| PSB + KOH and CHROMagarTM | 66 (28.2) | 65.3 |
| ITC and CIN | 50 (21.4) | 49.5 |
| ITC and CHROMagarTM | 43 (18.4) | 42.6 |
| ITC + KOH and CIN | 58 (24.8) | 57.4 |
| ITC + KOH and CHROMagarTM | 42 (17.9) | 41.6 |
Y. enterocolitica odds ratio and prevalence ratio between alkali-treated and untreated broths.
| Broth and Agar | Prevalence Ratio | Odds Ratio (OR) | Fisher Exact Test; | Confidence Interval (95% CI) |
|---|---|---|---|---|
| PSB + KOH and CIN vs. PSB and CIN | 5.42 | 7.41 | <0.0001 | 4.07–13.47 |
| PSB + KOH and CHROMagarTM vs. PSB and CHROMagarTM | 3.66 | 4.71 | <0.0001 | 2.71–8.19 |
| ITC + KOH and CIN vs. ITC and CIN | 1.15 | 1.21 | 0.44 | 0.78–1.86 |
| ITC + KOH and CHROMagarTM vs. ITC and CHROMagarTM | 0.97 | 0.97 | 1 | 0.60–1.55 |
Figure 1PFGE profiles of Y. enterocolitica 4/O:3 from different farm types, slaughterhouses, and years of isolation.
Prevalence and resistance patterns of multiresistant Y. enterocolitica 4/O:3 in pig tonsils from different farm types (2014).
| Farm Type | Resistance | Number of Resistant Isolates | Number of Tested Isolates | % of Multiresistant Isolates/Patterns |
|---|---|---|---|---|
| Big integrated | NA-CHL-STR | 13 | 24 | 54 |
| TET-NA-CHL-STR | 1 | 4 | ||
| TET-NA-CAZ-TMP/SMX | 1 | 4 | ||
| Medium-sized | NA-CHL-CFX | 1 | 25 | 4 |
NA: nalidixic acid, CHL: Chloramphenicol, STR: Streptomycin, TET: Tetracycline, CAZ: Ceftazidime, TMP/SMX: Trimethoprim/Sulfamethoxazole, CFX: Cefotaxime.
Prevalence and resistance patterns of multiresistant Y. enterocolitica 4/O:3 in pig tonsils from different farm types (2019).
| Farm | Resistance | Number of Resistant Isolates | Number of Tested Isolates | % of Multiresistant |
|---|---|---|---|---|
| Big integrated | NA-CHL-STR | 9 | 12 | 75 |
| TET-NA-CHL-CFX | 1 | 8 | ||
| Medium-sized | CAZ-TMP/SMX-STR | 1 | 59 | 2 |
| Small | NA-CAZ-TMP/SMX | 1 | 13 | 8 |
NA: nalidixic acid, CHL: Chloramphenicol, STR: Streptomycin, TET: Tetracycline, CAZ: Ceftazidime, TMP/SMX: Trimethoprim/Sulfamethoxazole, CFX: Cefotaxime.
Antimicrobial susceptibility of Y. enterocolitica 4/O:3 isolates collected in two surveys of tonsils from pigs raised in different housing systems.
| Antimicrobial | Big Integrated Farms | Medium-Sized Farms | Small Family Farms | Total | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S | I | R | S | I | R | S | I | R | S | I | R | |
| Levofloxacin | 36 | 0 | 0 | 81 | 3 | 0 | 13 | 0 | 0 | 130 | 3 | 0 |
| Ciprofloxacin | 36 | 0 | 0 | 84 | 0 | 0 | 13 | 0 | 0 | 133 | 0 | 0 |
| Ampicillin | 1 | 7 | 28 | 2 | 10 | 72 | 0 | 0 | 13 | 3 | 17 | 113 |
| Cephalothin | 2 | 5 | 29 | 16 | 2 | 66 | 0 | 0 | 13 | 18 | 7 | 108 |
| Cefotaxime | 35 | 0 | 1 | 81 | 2 | 1 | 13 | 0 | 0 | 129 | 2 | 2 |
| Tetracycline | 34 | 0 | 2 | 83 | 0 | 1 | 13 | 0 | 0 | 130 | 0 | 3 |
| Nalidixic acid | 9 | 0 | 27 | 76 | 3 | 5 | 12 | 0 | 1 | 97 | 3 | 33 |
| Ceftazidime | 35 | 0 | 1 | 79 | 2 | 3 | 12 | 0 | 1 | 126 | 2 | 5 |
| Trimethoprim/ Sulfamethoxazole | 34 | 1 | 1 | 83 | 0 | 1 | 12 | 0 | 1 | 129 | 1 | 3 |
| Chloramphenicol | 12 | 0 | 24 | 82 | 1 | 1 | 13 | 0 | 0 | 107 | 1 | 25 |
| Streptomycin | 11 | 3 | 22 | 72 | 8 | 4 | 10 | 1 | 2 | 93 | 12 | 28 |
S = sensitive, I = intermediate, R = resistant.
Antimicrobial susceptibility/resistance of Y. enterocolitica 4/O:3 isolates from big integrated farms.
| Antimicrobial | Year 2014 | Year 2019 | ||||
|---|---|---|---|---|---|---|
| S | I | R | S | I | R | |
| Levofloxacin | 24 | 0 | 0 | 12 | 0 | 0 |
| Ciprofloxacin | 24 | 0 | 0 | 12 | 0 | 0 |
| Ampicillin | 1 | 2 | 21 | 0 | 5 | 7 |
| Cephalothin | 1 | 5 | 18 | 0 | 0 | 12 |
| Cefotaxime | 24 | 0 | 0 | 11 | 0 | 1 |
| Tetracycline | 22 | 0 | 2 | 12 | 0 | 0 |
| Nalidixic acid | 9 | 0 | 15 | 0 | 0 | 12 |
| Ceftazidime | 23 | 0 | 1 | 12 | 0 | 0 |
| Trimethoprim/Sulfamethoxazole | 23 | 0 | 1 | 11 | 1 | 0 |
| Chloramphenicol | 9 | 0 | 15 | 3 | 0 | 9 |
| Streptomycin | 9 | 1 | 14 | 2 | 2 | 8 |
S = sensitive, I = intermediate, R = resistant.
Antimicrobial susceptibility/resistance of Y. enterocolitica 4/O:3 isolates from medium-sized farms.
| Antimicrobial | Year 2014 | Year 2019 | ||||
|---|---|---|---|---|---|---|
| S | I | R | S | I | R | |
| Levofloxacin | 25 | 0 | 0 | 56 | 0 | 3 |
| Ciprofloxacin | 25 | 0 | 0 | 59 | 0 | 0 |
| Ampicillin | 2 | 6 | 17 | 0 | 5 | 54 |
| Cephalothin | 0 | 2 | 23 | 0 | 0 | 59 |
| Cefotaxime | 22 | 2 | 1 | 59 | 0 | 0 |
| Tetracycline | 24 | 0 | 1 | 59 | 0 | 0 |
| Nalidixic acid | 23 | 0 | 2 | 53 | 3 | 3 |
| Ceftazidime | 24 | 1 | 0 | 55 | 1 | 3 |
| Trimethoprim/Sulfamethoxazole | 25 | 0 | 0 | 58 | 0 | 1 |
| Chloramphenicol | 24 | 0 | 1 | 58 | 1 | 0 |
| Streptomycin | 25 | 0 | 0 | 47 | 8 | 4 |
S = sensitive, I = intermediate, R = resistant.